GlassScriptPhysician profile
Alyssa Mathilde Ohs
NPI 1487040101
$1,274.74
in general payments reported to CMS, 2019-2025
22 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.56 · 2020: $94.15 · 2021: $142 · 2022: $91.63 · 2023: $383 · 2024: $288 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $203.68 | 2019-2024 | |
| Organon LLC | $193.23 | 2023-2025 | Nexplanon |
| Abbvie INC. | $141.73 | 2020-2022 | |
| Astellas Pharma US INC | $109.96 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $102.61 | 2023 | |
| Minerva Surgical, INC | $79.23 | 2023-2024 | |
| Exeltis, USA INC. | $59.09 | 2021-2025 | Slynd |
| Pfizer INC. | $42.90 | 2022-2023 | |
| Meditrina | $38.58 | 2023-2025 | |
| Sage Therapeutics, LLC | $37.71 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $29.80 | 2021-2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $29.70 | 2023 | Myosure Tissue Removal Device, Coolseal Generator, Acessa Provu System |
| Alexion Pharmaceuticals, INC. | $28.19 | 2023 | Ultomiris |
| Innovation Technologies INC | $24.82 | 2024 | Irrisept |
| Mission Pharmacal Company | $23.55 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $23.48 | 2024 | Dexcom G6 Transmitter |
| Agile Therapeutics, INC. | $20.89 | 2021 | |
| Millicent US INC | $20.63 | 2024 | Intrarosa |
| Exact Sciences Corporation | $19.67 | 2025 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $15.66 | 2023 | Exparel |
| Allergan, INC. | $14.84 | 2019 | |
| Currax Pharmaceuticals LLC | $14.79 | 2023 | Onzetra Xsail, Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Ohs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.